Nexalin Technology, Inc. Other Income and Expense
Nexalin Technology, Inc. (NXL) reported Other Income and Expense of $8.14 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Other Income
us-gaap:NonoperatingIncomeExpense · last filed 2026-08-12
- Nexalin Technology, Inc. nonoperating income (expense) for the quarter ending 2026-06-30 was $8.14K, a 79.57% decline year-over-year.
- Nexalin Technology, Inc. nonoperating income (expense) for the quarter ending 2026-03-31 was $23.07K, a 3.64% decline year-over-year.
- Nexalin Technology, Inc. nonoperating income (expense) for the quarter ending 2025-12-31 was $36.62K, a 12.64% decline year-over-year.
- Nexalin Technology, Inc. nonoperating income (expense) for the quarter ending 2025-09-30 was $69.32K, a 15.34% increase year-over-year.
- Nexalin Technology, Inc. nonoperating income (expense) for fiscal 2025 was $169.75K, a 19.03% increase from fiscal 2024.
- Nexalin Technology, Inc. nonoperating income (expense) for fiscal 2024 was $142.61K, a 86.39% decline from fiscal 2023.
- Nexalin Technology, Inc. nonoperating income (expense) for fiscal 2023 was $1.05M, a 674.76% increase from fiscal 2022.
- Nexalin Technology, Inc. nonoperating income (expense) for fiscal 2022 was $135.22K.
| Period end | Nonoperating Income (Expense) 3 month | Nonoperating Income (Expense) 6 month | Nonoperating Income (Expense) 9 month | Nonoperating Income (Expense) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $8.14K 10-Q · filed 2026-08-12 | $31.21K 10-Q · filed 2026-08-12 | $67.83K derived: sum of 3 quarters · filed 2026-08-12 | $137.15K derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $23.07K 10-Q · filed 2026-05-08 | $59.69K derived: sum of 2 quarters · filed 2026-05-08 | $129.01K derived: sum of 3 quarters · filed 2026-05-08 | $168.88K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $36.62K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $105.94K derived: sum of 2 quarters · filed 2026-03-25 | $145.81K derived: sum of 3 quarters · filed 2026-08-12 | $169.75K 10-K · filed 2026-03-25 |
| 2025-09-30 | $69.32K 10-Q · filed 2025-11-14 | $109.19K derived: sum of 2 quarters · filed 2026-08-12 | $133.13K 10-Q · filed 2025-11-14 | $175.05K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | $39.87K 10-Q · filed 2026-08-12 | $63.81K 10-Q · filed 2026-08-12 | $105.73K derived: sum of 3 quarters · filed 2026-08-12 | $165.83K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $23.94K 10-Q · filed 2026-05-08 | $65.86K derived: sum of 2 quarters · filed 2026-05-08 | $125.96K derived: sum of 3 quarters · filed 2026-05-08 | $139.78K derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $41.92K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $102.02K derived: sum of 2 quarters · filed 2026-03-25 | $115.84K derived: sum of 3 quarters · filed 2026-03-25 | $142.61K 10-K · filed 2026-03-25 |
| 2024-09-30 | $60.10K 10-Q · filed 2025-11-14 | $73.92K derived: sum of 2 quarters · filed 2025-11-14 | $100.69K 10-Q · filed 2025-11-14 | $944.50K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $13.82K 10-Q · filed 2025-08-06 | $40.59K 10-Q · filed 2025-08-06 | $884.39K derived: sum of 3 quarters · filed 2025-09-23 | $1.00M derived: sum of 4 quarters · filed 2025-09-23 |
| 2024-03-31 | $26.77K 10-Q · filed 2025-05-13 | $870.58K derived: sum of 2 quarters · filed 2025-09-23 | $988.92K derived: sum of 3 quarters · filed 2025-09-23 | $1.04M derived: sum of 4 quarters · filed 2025-09-23 |
| 2023-12-31 | $843.80K derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-09-23 | $962.15K derived: sum of 2 quarters · filed 2025-09-23 | $1.02M derived: sum of 3 quarters · filed 2025-09-23 | $1.05M 10-K/A · filed 2025-09-23 |
| 2023-09-30 | $118.35K 10-Q · filed 2024-11-08 | $172.77K derived: sum of 2 quarters · filed 2024-11-08 | $203.78K 10-Q · filed 2024-11-08 | $193.72K derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | $54.42K 10-Q · filed 2024-08-08 | $85.44K 10-Q · filed 2024-08-08 | $75.38K derived: sum of 3 quarters · filed 2024-08-08 | $233.17K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $31.01K 10-Q · filed 2024-05-10 | $20.95K derived: sum of 2 quarters · filed 2024-05-10 | $178.75K derived: sum of 3 quarters · filed 2024-05-10 | $161.44K derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | -$10.06K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $147.73K derived: sum of 2 quarters · filed 2024-03-27 | $130.43K derived: sum of 3 quarters · filed 2024-03-27 | $135.22K 10-K · filed 2024-03-27 |
| 2022-09-30 | $157.79K 10-Q · filed 2023-11-13 | $140.49K derived: sum of 2 quarters · filed 2023-11-13 | $145.28K 10-Q · filed 2023-11-13 | $103.92K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | -$17.30K 10-Q · filed 2023-08-10 | -$12.52K 10-Q · filed 2023-08-10 | -$53.87K derived: sum of 3 quarters · filed 2023-08-10 | -$58.13K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | -$18.13K 10-Q · filed 2023-05-10 | -$36.57K derived: sum of 2 quarters · filed 2023-05-10 | -$40.83K derived: sum of 3 quarters · filed 2023-05-10 | |
| 2021-12-31 | -$18.44K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | -$22.70K derived: sum of 2 quarters · filed 2023-03-27 | -$59.40K 10-K · filed 2023-03-27 | |
| 2021-09-30 | -$4.26K 10-Q · filed 2022-11-10 | -$40.96K 10-Q · filed 2022-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| EDAP TMS SA (FOCL) | $0.171B | ||
| IRIDEX CORP (IRIX) | United States | $0.011B |